Analysis of clinical treatment efficiency for 179 geriatric women with stage I or II cervical carcinoma
Tóm tắt
To evaluate the efficiency of surgery plus radiotherapy and chemotherapy versus radiotherapy plus chemotherapy in the treatment of older patients with stage I or II cervical carcinoma and to seek suitable treatment for such patients. The clinical data of 179 elderly women with stage la or lib cervical cancer were analyzed retrospectively. One hundred and thirty-four cases underwent radical hysterectomy followed by adjuvant radiotherapy and/or chemotherapy (Group 1). Forty-five cases underwent radiation therapy plus adjuvant chemotherapy (Group 2). The 5-year survival rates in group 1 and group 2 were 78.3% and 49.1%(P=0.04), respectively. The incidence of complications in groupi was 47.0%. Three patients died of complications after radical hysterectomy. The incidence of complications in group 2 was 75.6%. Elderly patients with stage I or II cervical carcinoma should receive an operation if possible. In addition they should receive adjuvant treatments according to their personal conditions, and be treated with appropriate adjuvant chemo-and/or radiotherapy.
Tài liệu tham khảo
Merrill RM, Feuer EJ. Risk-adjusted cancer incidence rates (United States). Cancer causes control. 1996;7:544–552.
Anttila A, Pukkala E, Soderman B, et al. Effect of organised sceening on cervical cancer incidence and mortality in Finland, 1963 -1995: recent increase in cervical cancer incidence. Int J Cancer. 1999;83:59–65.
Bergstrom R, Sparen P, Adami HO. Trends in cancer of the cervix uteri in Sweden following cytological screening. Br J Cancer. 1999;81:159–166.
Fletcher A. Screening for cancer of the cervix in elderly women. Lancet. 1990;335:97–99.
Minagawa Y, Kigawa J, Kanamori Y. Tumor cell kinetics in elderly patients with cervical cancer. Obstet Gynecol. 1993;81:610–614.
Forsmo S, Jacobsen BK, Stalsberg H. Cervical neoplasia in pap smears: risk of cervical intra—epithelial neoplasia (CIN) after negative or no prior smears in a population without a mass screening programme. Int J Epidemiol. 1996;25:53–58.
Chen RJ, Lin YH, Chen CA, et al. Influence of histologic type and age on survival rates lor invasive cervical carcinoma in Taiwan. Gynecol Oncol. 1999;73:184–190.
Chapman GW. Survival of advanced age females with cervical carcinoma. Gynecol Oncol. 1992;46:287–291.
Hopkins MP, Morley GW. Radical hysterectomy versus radiation therapy for stage IB squamous cell cancer of the cervix. Cancer. 1991; 68:272–277.
Li MD, Tan DC, Liu FY, et al. Analysis of the long-term effect of 2,676 cases with carcinoma of uterine cervix. Chin Cancer. 1983;2:225–227.
Grant PT, Jeffrey JF, Fraser RC, et al. Pelvic radiation therapy for gynecologic malignancy in geriatric patients. Gynecol Oncol. 1989;33:185–188.
Senkus-Konefka E, Kobierska A, Jassem J, et al. Influence of brachytherapy applicators geometry on dose distribution in cervical cancer. Int J Radiat Oncol Boil Phys. 1997;37: 531–536.
Chen SW, Liang JA, Yang SA. The prediction of late rectal complications following the treatment of uterine cervical cancer by high -dose -rate brachytherapy. Int J Radiat Oncol Boil Phys. 2000;47:955–961.
Moyses HM, Morrow CP, Muderspach LI, et al. Residual disease in the uterus after preoperative radiotherapy and hysterectomy in stage Ib cervical carcinoma. Am J Clin Oncol. 1996;19:433–438.
Levrant SG, Fruchter RG, Maiman M. Radical hysterectomy for cervical cancer: morbidity and survival in relation to weight and age. Gynecol Oncol. 1992;45:317–322.